Paying user area
Try for free
Danaher Corp. pages available for free this week:
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Danaher Corp. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Operating profit1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2025 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2008 | = | ÷ | = | ÷ | |||||||
| Mar 1, 2007 | = | ÷ | = | ÷ | |||||||
| Mar 15, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Danaher Corp. Annual Report.
The Price to Operating Profit (P/OP) ratio for the analyzed period exhibits considerable fluctuation, though generally trends upward over the long term. Initial values in the mid-teens give way to a significant dip during the 2008-2009 timeframe, followed by a period of relative stability and then a marked increase in the latter half of the period.
- Initial Period (2006-2009)
- From 2006 to 2007, the P/OP ratio decreased slightly from 15.18 to 14.52. A further decline occurred in 2008 to 13.65, before a substantial drop to 8.85 in 2009. This decrease in the P/OP ratio during 2008 and 2009 coincides with a decrease in share price, suggesting market reaction to economic conditions or company-specific challenges.
- Recovery and Stability (2010-2014)
- The P/OP ratio recovered to 15.63 in 2010, demonstrating a rebound in investor sentiment. From 2010 to 2014, the ratio remained relatively stable, fluctuating between 14.04 and 17.94. This period suggests a consolidation phase following the earlier downturn.
- Increasing Valuation (2015-2020)
- Beginning in 2015, the P/OP ratio began a more consistent upward trend. It increased from 17.27 in 2015 to 34.47 in 2019, peaking at 36.91 in 2020. This increase suggests growing investor confidence and a willingness to pay a higher premium for each dollar of operating profit. The increase in operating profit per share also contributed to this trend.
- Recent Volatility (2021-2026)
- The P/OP ratio experienced a significant decrease in 2021 to 25.14, followed by a further decline to 20.97 in 2022. A substantial increase to 35.64 was observed in 2023, before decreasing again to 30.56 and 31.54 in 2024 and 2025 respectively. This recent volatility indicates a period of fluctuating market perception, potentially influenced by broader economic factors or company-specific developments. The ratio remains elevated compared to the earlier years of the analyzed period.
Overall, the P/OP ratio demonstrates a long-term increasing trend, punctuated by periods of stability and volatility. The most significant fluctuations appear correlated with broader economic events and changes in operating profit per share.
Comparison to Competitors
| Danaher Corp. | AbbVie Inc. | Amgen Inc. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | |||||||
| Feb 20, 2025 | |||||||
| Feb 21, 2024 | |||||||
| Feb 22, 2023 | |||||||
| Feb 23, 2022 | |||||||
| Feb 25, 2021 | |||||||
| Feb 21, 2020 | |||||||
| Feb 21, 2019 | |||||||
| Feb 21, 2018 | |||||||
| Feb 22, 2017 | |||||||
| Feb 24, 2016 | |||||||
| Feb 25, 2015 | |||||||
| Feb 21, 2014 | |||||||
| Feb 22, 2013 | |||||||
| Feb 24, 2012 | |||||||
| Feb 24, 2011 | |||||||
| Feb 24, 2010 | |||||||
| Feb 25, 2009 | |||||||
| Feb 21, 2008 | |||||||
| Mar 1, 2007 | |||||||
| Mar 15, 2006 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).